Connect with us

Health Broadcasting Service

U.S. FDA moving to authorize Pfizer-BioNTech booster for 16-, 17-year-olds – WSJ

HBS Reporting

U.S. FDA moving to authorize Pfizer-BioNTech booster for 16-, 17-year-olds – WSJ

U.S. FDA moving to authorize Pfizer-BioNTech booster for 16-, 17-year-olds – WSJ

Nov 29 (Reuters) – The U.S. Food and Drug Administration could authorize COVID-19 boosters from Pfizer Inc (PFE.N) and BioNTech SE (22UAy.DE) for use in 16- and 17-year olds as soon as next week, the Wall Street Journal reported late on Monday, citing a person familiar with the planning.

Continue Reading
You may also like...
Click to comment

Leave a Reply

Your email address will not be published.

More in HBS Reporting